Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.
about
Myc-driven overgrowth requires unfolded protein response-mediated induction of autophagy and antioxidant responses in Drosophila melanogasterAutoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosisSecondary acute myeloid leukemia after successful treatment for osteosarcoma.Hodgkin lymphoma in a thymic cyst: report of a case with multiple secondary neoplasmsPharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma.Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor StudyProgress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating riskSynthesis and characterization of DNA minor groove binding alkylating agentsThe low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trialMethodological choices affect cancer incidence rates: a cohort studyCytogenetic instability in childhood acute lymphoblastic leukemia survivors.Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.Relapsed or refractory pediatric acute lymphoblastic leukemia: current and emerging treatments.Metabolic syndrome in patients with hematological diseases.Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis.Topoisomerase 2β: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity.Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature.Maxilla unilateral swelling as the first diagnostic symptom of acute lymphoblastic leukemia relapse: a case report.Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.Erythroleukemia relapsing as precursor B-cell lymphoblastic leukemia.Hematologic adverse events associated with temozolomide.Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia.Development of Secondary Acute Myeloid Leukemia in a Pediatric Patient Concurrently Receiving Primary Therapy for Ewing Sarcoma.Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.
P2860
Q27320947-EF05FA5B-6F18-4829-AC57-53B694EC01C3Q28299956-FF71533C-52BD-4163-B050-07EC5CDBD65EQ33392211-200015CC-7FFB-4EA3-8C91-424188B95A54Q33943212-73C4DCAC-4C92-42B9-B0F8-DE9EB2813716Q34422585-0E7DD80C-41DD-43A3-9646-E3BFF4B3C9A7Q34660375-BDB79224-A280-4CF6-B92B-15E09960011AQ35067402-BA2AD735-5C66-4264-A11D-28901B338F5FQ35706804-C8061EF1-CB46-4BBC-AB4F-1FABCE2AA90FQ36736612-13589AC5-B080-433A-9998-E13A74A3787DQ36746192-5B0834DA-0379-4331-B935-AB412A5C174CQ37078647-6C884EB1-99F9-4DAF-A6FD-03974B6EFF01Q37129069-56ECAEC2-5AB9-4D75-A560-6B4EEFAEAC58Q37595747-7F0C139E-C0B3-481C-81BE-490E79779CBCQ37792821-582942DA-4EBA-4ECF-8236-4C55D3A8D4DCQ38019607-3D116674-4FBC-4A09-A264-54E4ACA2E562Q38033592-634D54A2-E7E4-44A9-8870-FECB2C110FAEQ38044776-356BC5E8-C0CD-4C1A-A0BD-CD04EB343BDDQ38080583-2F976679-AE03-4941-8FE4-842FC1BDEABFQ38148968-48D9C2BD-7CA7-4EB0-B538-845865772258Q38221521-EBE615B5-7B77-4764-85E4-8FB58E2BC5E8Q38606020-B5169389-F4B9-47F9-AD0F-DE638F0C4BEAQ40260616-6C40A6DD-91D8-4D89-96D4-8D2181E34807Q42759571-4E57F544-3B4A-4FBC-B204-7592B443BDEAQ43998950-F7CF4577-67F4-4841-A9FA-1B0F134A1431Q50220583-0720C032-159A-43CE-B5ED-6B648682E4B5Q51806197-E750A07C-4CC1-4381-A501-D62FD69CDF39Q52330375-EA3EB1A1-4385-4C1F-9AFF-83851B07993E
P2860
Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acute leukemia as a secondary ...... : current findings and issues.
@en
Acute leukemia as a secondary ...... : current findings and issues.
@nl
type
label
Acute leukemia as a secondary ...... : current findings and issues.
@en
Acute leukemia as a secondary ...... : current findings and issues.
@nl
prefLabel
Acute leukemia as a secondary ...... : current findings and issues.
@en
Acute leukemia as a secondary ...... : current findings and issues.
@nl
P2093
P2860
P356
P1433
P1476
Acute leukemia as a secondary ...... : current findings and issues.
@en
P2093
Kirsten K Ness
Melissa M Hudson
Nobuko Hijiya
Raul C Ribeiro
P2860
P356
10.1002/CNCR.23988
P407
P577
2009-01-01T00:00:00Z